DK1471073T3 - Hepatitis C-virus-asialoglycoproteiner - Google Patents
Hepatitis C-virus-asialoglycoproteinerInfo
- Publication number
- DK1471073T3 DK1471073T3 DK04076119T DK04076119T DK1471073T3 DK 1471073 T3 DK1471073 T3 DK 1471073T3 DK 04076119 T DK04076119 T DK 04076119T DK 04076119 T DK04076119 T DK 04076119T DK 1471073 T3 DK1471073 T3 DK 1471073T3
- Authority
- DK
- Denmark
- Prior art keywords
- hcv
- mannose
- binding protein
- ags
- compsn
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 13
- 108010002913 Asialoglycoproteins Proteins 0.000 title 1
- 102000009112 Mannose-Binding Lectin Human genes 0.000 abstract 5
- 108010087870 Mannose-Binding Lectin Proteins 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- 108010062580 Concanavalin A Proteins 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 101710186708 Agglutinin Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 1
- 241000234271 Galanthus Species 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 101710146024 Horcolin Proteins 0.000 abstract 1
- 101710189395 Lectin Proteins 0.000 abstract 1
- 101710179758 Mannose-specific lectin Proteins 0.000 abstract 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 abstract 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 abstract 1
- 102000007365 Sialoglycoproteins Human genes 0.000 abstract 1
- 108010032838 Sialoglycoproteins Proteins 0.000 abstract 1
- 239000000910 agglutinin Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003149 assay kit Methods 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61141990A | 1990-11-08 | 1990-11-08 | |
| US75888091A | 1991-09-13 | 1991-09-13 | |
| PCT/US1991/008272 WO1992008734A1 (en) | 1990-11-08 | 1991-11-07 | Hepatitis c virus asialoglycoproteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1471073T3 true DK1471073T3 (da) | 2009-01-26 |
Family
ID=27086508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04076119T DK1471073T3 (da) | 1990-11-08 | 1991-11-07 | Hepatitis C-virus-asialoglycoproteiner |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1471073B1 (da) |
| AT (2) | ATE264868T1 (da) |
| DE (2) | DE69133382T3 (da) |
| DK (1) | DK1471073T3 (da) |
| ES (2) | ES2218629T5 (da) |
| IE (1) | IE913916A1 (da) |
| PL (1) | PL175610B1 (da) |
| RO (1) | RO117920B1 (da) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
-
1991
- 1991-11-07 ES ES97120661T patent/ES2218629T5/es not_active Expired - Lifetime
- 1991-11-07 PL PL91300038A patent/PL175610B1/pl unknown
- 1991-11-07 DE DE69133382T patent/DE69133382T3/de not_active Expired - Lifetime
- 1991-11-07 DK DK04076119T patent/DK1471073T3/da active
- 1991-11-07 RO RO97-01809A patent/RO117920B1/ro unknown
- 1991-11-07 ES ES04076119T patent/ES2314334T3/es not_active Expired - Lifetime
- 1991-11-07 AT AT97120661T patent/ATE264868T1/de not_active IP Right Cessation
- 1991-11-07 AT AT04076119T patent/ATE414102T1/de not_active IP Right Cessation
- 1991-11-07 EP EP04076119A patent/EP1471073B1/en not_active Expired - Lifetime
- 1991-11-07 DE DE69133609T patent/DE69133609D1/de not_active Expired - Lifetime
- 1991-11-08 IE IE391691A patent/IE913916A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE414102T1 (de) | 2008-11-15 |
| IE913916A1 (en) | 1992-05-20 |
| EP1471073B1 (en) | 2008-11-12 |
| EP1471073A3 (en) | 2004-12-01 |
| ATE264868T1 (de) | 2004-05-15 |
| ES2218629T3 (es) | 2004-11-16 |
| PL175610B1 (pl) | 1999-01-29 |
| IE970761A1 (en) | 2000-02-23 |
| EP1471073A2 (en) | 2004-10-27 |
| DE69133609D1 (de) | 2008-12-24 |
| ES2218629T5 (es) | 2009-06-02 |
| RO117920B1 (ro) | 2002-09-30 |
| ES2314334T3 (es) | 2009-03-16 |
| DE69133382T2 (de) | 2005-05-04 |
| DE69133382T3 (de) | 2009-10-08 |
| DE69133382D1 (de) | 2004-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hiremath et al. | Immunological detection of the messenger RNA cap-binding protein. | |
| Nishi et al. | Purification of human, dog and rabbit α-fetoprotein by immunoadsorbents of Sepharose coupled with anti-human α-fetoprotein | |
| Mackin et al. | The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities. | |
| FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
| PT1084136E (pt) | Separacao de monomeros de anticorpos dos seus multimeros atraves da utilizacao de cromatografia de troca ionica | |
| ES8100502A1 (es) | Un procedimiento para purificar proteinas con pesos moleculares superiores a 12.000,en particular interferon | |
| BR9809443A (pt) | Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão. | |
| Thorpe et al. | Studies on papain produced subunits of human γG-globulins—II: Structures of peptides related to the genetic Gm activity of γG-globulin Fc-fragments | |
| EP0696640A3 (de) | Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus | |
| FR2677767B1 (fr) | Procede de detection de l'infection par le virus de la diarrhee bovine, sequence nucleotidique codant pour une proteine induite par l'infection par ce virus et proteines et antigenes recombinants s'y rapportant . | |
| DK1471073T3 (da) | Hepatitis C-virus-asialoglycoproteiner | |
| ES2170195T3 (es) | Peptidos del virus de epstein-barr y anticuerpos contra estos peptidos. | |
| Rybicki | Affinity purification of specific antibodies from plant virus capsid protein immobilised on nitrocellulose | |
| Novick et al. | Ligand affinity chromatography, an indispensable method for the purification of soluble cytokine receptors and binding proteins | |
| Tallet et al. | One-step chromatographic purification procedure of a His-tag recombinant carboxyl half part of the HTLV-I surface envelope glycoprotein overexpressed in Escherichia coli as a secreted form | |
| Proost et al. | Posttranslational processing of chemokines | |
| Philipson et al. | Interaction between poliovirus and immunoglobulins: I. Detection of virus antibodies by partition in aqueous polymer phase systems | |
| Pestka et al. | Monoclonal antibodies can discriminate between some active and inactive forms of leukocyte interferon | |
| Ball et al. | Lentivirus antigen purification and characterization: isolation of equine infectious anemia virus gag and env proteins in one step by reverse phase HPLC and application to human immunodeficiency virus glycoproteins | |
| EP1321476B1 (en) | Binding protein | |
| Fassina | Protein A Mimetic (PAM) Affinity Chromatography: Immunoglobulins Purification | |
| Schröder et al. | Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet-factor 4 | |
| Schröder | Isolation and purification of neutrophil-activating peptide-4: a chemokine missing two cysteines | |
| FUCHSBERGER et al. | Priming with interferon-α1 or interferon-α2 enhances the production of both subtypes simultaneously | |
| Van Damme et al. | Isolation of human monocyte chemotactic proteins and study of their producer and responder cells by immunotests and bioassays |